Literature DB >> 21324976

Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.

Teresa Bellón1, Virginia Martínez, Baltasar Lucendo, Gloria del Peso, María José Castro, Luiz S Aroeira, Aranzazu Rodríguez-Sanz, Marta Ossorio, Rafael Sánchez-Villanueva, Rafael Selgas, María Auxiliadora Bajo.   

Abstract

BACKGROUND: Depending on the cytokine microenvironment, macrophages (Mϕ) can adopt a proinflammatory (M1) or a profibrotic (M2) phenotype characterized by the expression of cell surface proteins such as CD206 and CD163 and soluble factors such as CC chemokine ligand 18 (CCL18). A key role for Mϕ in fibrosis has been observed in diverse organ settings. We studied the Mϕ population in a human model of peritoneal dialysis in which continuous stress due to dialysis fluids and recurrent peritonitis represent a risk for peritoneal membrane dysfunction reflected as ultrafiltration failure (UFF) and peritoneal fibrosis.
METHODS: We used flow cytometry and quantitative reverse transcription-polymerase chain reaction to analyse the phenotype of peritoneal effluent Mϕ and tested their ability to stimulate the proliferation of human fibroblasts. Mϕ from non-infected patients were compared with those from patients with active peritonitis. Cytokine production was evaluated by enzyme-linked immunosorbent assay (ELISA) in spent dialysates and cell culture supernatants.
RESULTS: CD206(+) and CD163(+) M2 were found within peritoneal effluents by flow cytometry analysis, with increased frequencies of CD163(+) cells during peritonitis (P = 0.003). TGFB1, MMP9 and CCL18 messenger RNA (mRNA) levels in peritoneal macrophages (pMϕ) were similar to those found in M2 cells differentiated in vitro. The ability of pMϕ to stimulate fibroblast proliferation correlated with CCL18 mRNA levels (r = 0.924, P = 0.016). CCL18 production by pMϕ was confirmed by immunostaining of cytospin samples and ELISA. Moreover, CCL18 effluent concentrations correlated with decreased peritoneal function, which was evaluated as dialysate to plasma ratio of creatinine (r = 0.724, P < 0.0001), and were significantly higher in patients with UFF (P = 0.0025) and in those who later developed sclerosing peritonitis (P = 0.024).
CONCLUSIONS: M2 may participate in human peritoneal fibrosis through the stimulation of fibroblast cell growth and CCL18 production as high concentrations of CCL18 are associated with functional deficiency and fibrosis of the peritoneal membrane.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324976     DOI: 10.1093/ndt/gfq771

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  45 in total

Review 1.  Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.

Authors:  Anneleen Pletinck; Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-07-10       Impact factor: 28.314

2.  Characterization of Distinct Macrophage Subpopulations during Nitrogen Mustard-Induced Lung Injury and Fibrosis.

Authors:  Alessandro Venosa; Rama Malaviya; Hyejeong Choi; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

3.  Profibrotic Activation of Human Macrophages in Systemic Sclerosis.

Authors:  Rajan Bhandari; Michael S Ball; Viktor Martyanov; Dillon Popovich; Evelien Schaafsma; Saemi Han; Mohamed ElTanbouly; Nicole M Orzechowski; Mary Carns; Esperanza Arroyo; Kathleen Aren; Monique Hinchcliff; Michael L Whitfield; Patricia A Pioli
Journal:  Arthritis Rheumatol       Date:  2020-05-31       Impact factor: 10.995

4.  Inductive, scaffold-based, regenerative medicine approach to reconstruction of the temporomandibular joint disk.

Authors:  Bryan N Brown; William L Chung; Alejandro J Almarza; Matthew D Pavlick; Serafim N Reppas; Mark W Ochs; Alan J Russell; Stephen F Badylak
Journal:  J Oral Maxillofac Surg       Date:  2012-02-25       Impact factor: 1.895

Review 5.  Macrophage phenotypes during tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  J Leukoc Biol       Date:  2013-03-15       Impact factor: 4.962

Review 6.  Repertoire of microglial and macrophage responses after spinal cord injury.

Authors:  Samuel David; Antje Kroner
Journal:  Nat Rev Neurosci       Date:  2011-06-15       Impact factor: 34.870

7.  The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.

Authors:  Lei Zhang; Jian-Bing Hao; Lian-Sheng Ren; Jiu-Li Ding; Li-Rong Hao
Journal:  Lab Invest       Date:  2014-05-26       Impact factor: 5.662

8.  A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages.

Authors:  Rahul K Keswani; Gi S Yoon; Sudha Sud; Kathleen A Stringer; Gus R Rosania
Journal:  Cytometry A       Date:  2015-06-24       Impact factor: 4.355

9.  Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis.

Authors:  Catriona Goodlad; Frederick W K Tam; Sohail Ahmad; Gurjeet Bhangal; Bernard V North; Edwina A Brown
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.

Authors:  Nahal Mansouri; Gareth R Willis; Angeles Fernandez-Gonzalez; Monica Reis; Sina Nassiri; S Alex Mitsialis; Stella Kourembanas
Journal:  JCI Insight       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.